Ignite Creation Date:
2024-10-26 @ 3:37 PM
Last Modification Date:
2024-10-26 @ 3:37 PM
Study NCT ID:
NCT06549361
Status:
COMPLETED
Last Update Posted:
None
First Post:
2024-08-08
Brief Title:
A Retrospective Study on Extranodal DLBCL
Sponsor:
None
Organization:
None
Study Overview
Official Title:
The Retrospective Clinical Study of Extranodal Diffuse Large B-Cell Lymphoma
Status:
COMPLETED
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The aim of this study is to prospectively collect clinical information of patients with extranodal DLBCL assess the effectiveness of treatment for extranodal DLBCL in the real world and explore the optimal treatment strategies in real-world populations
Detailed Description:
DLBCL is a highly common aggressive non-Hodgkins lymphoma For specific extranodal sites of DLBCL traditional chemotherapy protocols often cannot provide satisfactory results for patients The aim of this study is to prospectively collect clinical information of patients with extranodal DLBCL including the distribution of involved sites such as central nervous system testes skin breast gastrointestinal tract etc prognosis of diffuse large B-cell lymphoma with involvement of different extranodal sites genetic mutation characteristics correlation with molecular subtypes impact of different treatment regimens on efficacy assess the effectiveness of treatment for extranodal DLBCL in the real world and explore the optimal treatment strategies in real-world populations
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None